Welsner, M.; Stehling, F.; Gruber, W.; Westhölter, D.; Sutharsan, S.; Taube, C.; Büscher, E.; Nensa, F.; Zensen, S.; Umutlu, L.;
et al. Impact of Elexacaftor–Tezacaftor–Ivacaftor on Muscle Composition in Cystic Fibrosis: An AI-Assisted Chest CT-Based Body Composition Analysis. Med. Sci. 2025, 13, 284.
https://doi.org/10.3390/medsci13040284
AMA Style
Welsner M, Stehling F, Gruber W, Westhölter D, Sutharsan S, Taube C, Büscher E, Nensa F, Zensen S, Umutlu L,
et al. Impact of Elexacaftor–Tezacaftor–Ivacaftor on Muscle Composition in Cystic Fibrosis: An AI-Assisted Chest CT-Based Body Composition Analysis. Medical Sciences. 2025; 13(4):284.
https://doi.org/10.3390/medsci13040284
Chicago/Turabian Style
Welsner, Matthias, Florian Stehling, Wolfgang Gruber, Dirk Westhölter, Sivagurunathan Sutharsan, Christian Taube, Erik Büscher, Felix Nensa, Sebastian Zensen, Lale Umutlu,
and et al. 2025. "Impact of Elexacaftor–Tezacaftor–Ivacaftor on Muscle Composition in Cystic Fibrosis: An AI-Assisted Chest CT-Based Body Composition Analysis" Medical Sciences 13, no. 4: 284.
https://doi.org/10.3390/medsci13040284
APA Style
Welsner, M., Stehling, F., Gruber, W., Westhölter, D., Sutharsan, S., Taube, C., Büscher, E., Nensa, F., Zensen, S., Umutlu, L., Forsting, M., Haubold, J., Salhöfer, L., Holtkamp, M., Kohnke, J., Hosch, R., & Opitz, M.
(2025). Impact of Elexacaftor–Tezacaftor–Ivacaftor on Muscle Composition in Cystic Fibrosis: An AI-Assisted Chest CT-Based Body Composition Analysis. Medical Sciences, 13(4), 284.
https://doi.org/10.3390/medsci13040284
